|
POLK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62579999996026E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.32540000000481E-05 |
| Normal-vs-Stage2 |
4.638700E-03 |
| Normal-vs-Stage3 |
1.23149999975425E-07 |
| Normal-vs-Stage4 |
2.49149999997922E-06 |
| Stage1-vs-Stage2 |
8.027000E-01 |
| Stage1-vs-Stage3 |
8.546200E-02 |
| Stage1-vs-Stage4 |
1.491410E-01 |
| Stage2-vs-Stage3 |
1.592160E-01 |
| Stage2-vs-Stage4 |
1.907370E-01 |
| Stage3-vs-Stage4 |
8.766400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.03939999957548E-07 |
| Normal-vs-AfricanAmerican |
2.255800E-01 |
| Normal-vs-Asian |
1.371500E-04 |
| Caucasian-vs-AfricanAmerican |
4.825900E-02 |
| Caucasian-vs-Asian |
9.038000E-01 |
| AfricanAmerican-vs-Asian |
8.765800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.9482999998669E-07 |
| Normal-vs-Female |
1.85510999999305E-05 |
| Male-vs-Female |
4.388200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.988900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62820000004782E-06 |
| Normal-vs-Age(61-80Yrs) |
2.0350999999974E-05 |
| Normal-vs-Age(81-100Yrs) |
1.403810E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.940010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.023800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.455200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.558000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.102200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.974800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.566100E-02 |
| Classical-VS-Follicular |
3.372600E-01 |
| Classical-VS-Other |
4.291800E-01 |
| Classical-VS-Normal |
1.89735999999163E-05 |
| Tall-VS-Follicular |
1.881630E-02 |
| Tall-VS-Other |
9.363200E-01 |
| Tall-VS-Normal |
4.43670000005447E-06 |
| Follicular-VS-Other |
3.369000E-01 |
| Follicular-VS-Normal |
6.135200E-03 |
| Other-VS-Normal |
1.337970E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.65880000005492E-06 |
| Normal-vs-N1 |
1.405310E-04 |
| N0-vs-N1 |
9.564400E-01 |
|
|
